Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Asset Utilization Ratio (2020 - 2025)

Revolution Medicines has reported Asset Utilization Ratio over the past 6 years, most recently at 0.0 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 0.0 (changed N/A YoY), and the annual figure for FY2023 was 0.01, down 82.35%.
  • Asset Utilization Ratio for Q4 2025 was 0.0 at Revolution Medicines, up from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for RVMD hit a ceiling of 0.06 in Q1 2021 and a floor of 0.0 in Q3 2025.
  • Median Asset Utilization Ratio over the past 5 years was 0.04 (2023), compared with a mean of 0.03.
  • Biggest five-year swings in Asset Utilization Ratio: rose 8.26% in 2022 and later plummeted 1274.97% in 2025.
  • Revolution Medicines' Asset Utilization Ratio stood at 0.04 in 2021, then grew by 8.26% to 0.04 in 2022, then crashed by 82.4% to 0.01 in 2023, then plummeted by 94.54% to 0.0 in 2024, then dropped by 13.27% to 0.0 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q3 2024) per Business Quant data.